Fenfluramine as an oral antidiabetic
Hepp, K.D.
Münchener Medizinische Wochenschrift 125(46): 126-127
1983
ISSN/ISBN: 0341-3098 PMID: 6417535 Document Number: 218702
Document emailed within 1 workday
Related Documents
Johansen, K. 2001: New oral antidiabetic glitazones Ugeskrift for Laeger 164(1): 76-77Schroner, Z.; Javorsky, M.; Kozarova, M.; Tkac, I. 2011: Pharmacogenetics of oral antidiabetic treatment Bratislavske Lekarske Listy 112(8): 441-446
Schumm-Draeger, P-Maria. 2006: Current treatment with oral antidiabetic agents MMW Fortschritte der Medizin 148(9): 33-35
Koivisto, V. 1999: Insulin analogs and new oral antidiabetic drugs Duodecim; Laaketieteellinen Aikakauskirja 115(20): 2197-2202
Haslbeck, M. 1979: New aspects of therapy with oral antidiabetic agents Wiener Medizinische Wochenschrift 199(24): 689-695
Behpour, A. 1980: Diabetes in adults and old age. Treatment with an oral antidiabetic agent Zfa. Zeitschrift für Allgemeinmedizin 56(22): 1412-1414
Blumenbach, L.; Gerhards, E.; Gutsche, H.; Klein, W.; Loge, O.; Losert, W.; Schillinger, E.; Speck, U.; Vetter, H.; Wendt, H. 1975: Gliflumide, a new oral antidiabetic of high potency and efficacy International Journal of Clinical Pharmacology and Biopharmacy 12(1-2): 141-151
Dhirawani, M.K.; Patel, J.C.; Kabadi, U.M. 1970: A clinical trial with glycodiazine--a new oral antidiabetic compound Indian Journal of Medical Sciences 24(2): 53-62
Krylov, A.A.; Gordienko, E.A. 1970: Hematologic complications during prolonged use of antidiabetic oral preparations Problemy Endokrinologii 16(1): 36-37
Stańczyk, J.; Otto-Buczkowska, E.; Jarosz-Chobot, P.ła.; Nowowiejska, B. 2008: Used of oral antidiabetic agents in pediatric patients - own observations Endokrynologia Polska 59(5): 434-443
Sieberová, R. 1971: Clinical experiences with administration of oral antidiabetic agent Buformin Casopis Lekaru Ceskych 110(18): 420-421
Francia, E.; Marin, A.; Verdejo, F.; Sanchez, M.S.; Morell, J. 1975: New oral antidiabetic drugs. Synthesis and structure-activity relationships Bollettino Chimico Farmaceutico 114(7): 379-392
D'Onofrio, F.; Pempinello, R.; Romis, L. 1972: Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide Arzneimittel-Forschung 22(11): 1879-1881
Leubner, H. 1973: Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563) Wiener Medizinische Wochenschrift 123(17): 277-282
Uglesic, A.; Ljahnicky, N. 1975: Experiences with the oral antidiabetic agent, Glurenorm, in diabetics with kidney diseases Medizinische Monatsschrift 29(9): 408-411
Kawai, K.; Kawasaki-Tokui, Y.; Odaka, T.; Tsuruta, F.; Kazui, M.; Iwabuchi, H.; Nakamura, T.; Kinoshita, T.; Ikeda, T.; Yoshioka, T.; Komai, T.; Nakamura, K. 1997: Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs Arzneimittel-Forschung 47(4): 356-368
Beringer, A. 1974: Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination Minerva Medica 65(60): 3127-3139
Fabbian, F.; De Giorgi, A.; Monesi, M.; Tiseo, R.; Storari, A.; Mallozzi Menegatti, A.; Pala, M.; Tomasi, F.; Portaluppi, F.; Manfredini, R. 2014: Prescription of oral antidiabetic drugs in K/DIGO chronic kidney disease stage 3 and 4: a single centre report Minerva Urologica e Nefrologica 66(1): 69-75
Kuritzky, L. 2006: Addition of basal insulin to oral antidiabetic agents: a goal-directed approach to type 2 diabetes therapy Medgenmed: Medscape General Medicine 8(4): 34
Schmitt, E.W.; Nijssen, J. 1978: Glibornuride--field study on an oral antidiabetic agent. Results of therapy with gluboride in a large number of patients Die Medizinische Welt 29(29-30): 1170-1174